Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInduction Heal. Regulatory News (INHC)

  • This share is currently suspended. It was suspended at a price of 9.75
  • There is currently no data for INHC

Strategic Collaboration Between Cerner & Induction

12 Oct 2020 07:00

RNS Number : 7037B
Induction Healthcare Group PLC
12 October 2020
 

12 October 2020

 

Induction Healthcare Group PLC

 

("Induction", the "Company", or the "Group")

 

Strategic Collaboration Between Cerner and Induction Healthcare

 

- Value added reseller agreement: NHS Trusts who are Cerner clients can access Zesty products through their existing agreements

- Improving patient experience: strategic collaboration to help NHS hospitals make it easier for patients to manage their outpatient appointments and correspondence online

 

Induction, a leading healthcare technology company that helps healthcare professionals deliver better care more efficiently, announces a strategic collaboration with Cerner Corporation (Nasdaq: CERN), a global health care technology company.

 

Zesty, Induction's market-leading patient portal for hospitals, and Cerner will develop a joint patient engagement solution to help NHS trusts deliver an easier, quicker and more efficient service for patients. This collaboration will closely align existing patient facing technology in the UK and Ireland, building on the benefits of Cerner's patient portal solution Healthelifeand Zesty's integration capability with Cerner's electronic health record (EHR), Cerner Millennium®.

 

NHS Trusts are expected to help patients manage outpatient appointments, complete remote care questionnaires, and view hospital correspondence on their own mobile phones - helping to reduce delays and costs associated with posting letters, reducing demands on administrative, medical and nursing staff, and significantly improving patient experience and access to care options.

 

As part of the value added reseller (VAR) agreement, NHS Trusts that are already Cerner clients will have access to Zesty's market-leading patient portal under their existing contractual arrangements.

 

Cerner is a leader in health care technology interoperability and embeds standards and guidance in support of open approaches to data sharing between systems. Cerner was one of the first signatories of techUK's Health and Social Care Interoperability Charter, co-founding the UK's INTEROpen interoperability industry group while championing FHIR® in the UK, and having been a long-time supporter of the Professional Records Standards Body, as well as its predecessor in the Royal College of Physicians.

 

This strategic collaboration has the potential to generate material revenues for Induction in the year ending 31 March 2022, in keeping with the company's strategic focus.

 

James Balmain, Joint-CEO of Induction Healthcare, said:

"It is a landmark moment for Zesty to be selected by Cerner in the UK and Ireland to jointly develop patient engagement solutions for NHS hospitals. Together, our organisations can provide staff and patients with world class digital tools to manage their care and operate more efficiently in the current environment of rapidly changing and unfamiliar conditions. The prospect of a patient facing platform that represents the best of Zesty and the best of Cerner will be game-changing for both existing and new Cerner customers."

 

Distie Profit, Managing Director of Cerner UK, said:

"We will all be patients at some stage in our life, which is why Cerner is committed to providing our clients with scalable and interoperable solutions that help them create the best possible experience for their patients. Helping patients become more engaged and empowered through access to their health information allows them to receive care remotely and better manage their health."

 

"This new collaboration with Zesty is expected to provide a more streamlined experience for both patients and health care professionals and reaffirms our commitment to improving the outcomes for all individuals by creating innovative solutions and collaborations to benefit our clients."

 

In the UK, Cerner's powerful, open and interoperable Cerner EHR is utilised by more than144,000 health and care professionals across 24 NHS Trusts to manage 1.5 million patients every month. Its Health Information Exchange (HIE) shares more than 19 million health records, and its population health intelligence platform, HealtheIntent®, is contracted to help clients proactively manage and improve the health of more than 9.5 million individuals.

 

 

 

ENQUIRIES

 

Induction Healthcare

Via FTI Consulting

Dr Hugo Stephenson, Joint Chief Executive Officer

James Balmain, Joint Chief Executive Officer

Numis Securities (Nominated Adviser and Broker)

+44 (0) 207 260 1000

James Black / Freddie Barnfield / Huw Jeremy / Matthew Jones

FTI Consulting

+44 (0) 203 727 1000

Jamie Ricketts / Elena Kalinskaya / Sam Purewal / Mary Whittow

 

 

About Induction

 

Induction Healthcare Group PLC is a leading healthcare technology company that helps healthcare professionals deliver better care more efficiently. The Group has three platforms, Induction [Switch] and MicroGuide, that support healthcare professionals in multiple markets, including the UK, Ireland, Australia & South Africa, plus Zesty, a leading provider of patient portals to NHS Hospitals in the UK.

 

Induction Switch is the number one healthcare collaboration app in the UK, used by the majority of hospital doctors within the NHS. The app helps over 140,000 registered users in multiple territories to increase productivity and enhance communication by securely sharing phone numbers and bleeps, bookmarks, documents and messages in a clinical setting.

 

The MicroGuide platform provides medical organisations with the ability to collaboratively create, edit, and publish their own local medical guidelines in a secure and locally administrated environment. The platform helps over 170,000 registered users in multiple territories, including the majority of hospital trusts within the NHS.

 

The Zesty platform enables patients to manage their care direct from their smartphone. The Zesty patient portal removes the friction from everyday health related tasks, like booking and managing appointments, reading letters digitally and sharing copies of electronic medical records.

 

About Cerner

Cerner's health technologies connect people and information systems in thousands of contracted provider facilities worldwide dedicated to creating smarter and better care for individuals and communities.

 

Recognized globally for innovation, Cerner assists clinicians in making care decisions and assists organizations in managing the health of their populations. The company also offers an integrated clinical and financial system to help manage day-to-day revenue functions, as well as a wide range of services to support clinical, financial and operational needs, focused on people. For more information, visit Cerner.comThe Cerner Blog or connect on FacebookInstagram, LinkedIn, Twitter or The Cerner Podcast. Nasdaq: CERN. Health care is too important to stay the same.

 

Trademark reference

 

Zesty and Induction Healthcare logos are registered trademarks of Induction Healthcare Group PLC. Cerner, Cerner Millennium and HealtheIntent are registered trademarks of Cerner Corporation or its affiliates.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ALLMLBLTMTBMBPM
Date   Source Headline
27th Jul 202210:30 amRNSBlock Listing Six Monthly Return
11th Jul 20227:00 amRNSDistribution agreement for Zesty with System C
5th Jul 20227:01 amEQSEdison Investment Research Limited: Induction Healthcare Group (INHC) initiation – Evolving technology in healthcare
7th Jun 20227:00 amRNSDirectorate Change
31st May 202212:58 pmRNSHolding(s) in Company
4th May 20227:00 amRNSDirectorate Change
29th Apr 20227:00 amRNSTotal Voting Rights
21st Apr 20227:00 amRNSPost-period end Trading Update
13th Apr 20224:01 pmRNSHolding(s) in Company
12th Apr 20224:00 pmRNSPurchase of Shares by Director
12th Apr 202212:11 pmRNSHolding(s) in Company
12th Apr 20227:00 amRNSPurchase of Shares by Directors
11th Apr 20227:00 amRNSNHS England contract renewals secure £6.6m ARR
7th Apr 20229:27 amRNSHolding(s) in Company
4th Apr 20227:00 amRNSFour London NHS Trusts sign with Induction Zesty
30th Mar 202211:00 amRNSAIM Rule 17 Schedule 2(g) Update
21st Mar 20227:00 amRNSNHS Scotland & Scottish Govt. Contract Renewals
26th Jan 20227:00 amRNSBlock Listing Six Monthly Return
6th Dec 20217:00 amRNSInduction AA rolls out new services nationwide
2nd Dec 202112:20 pmRNSPurchase of Shares by Directors
2nd Dec 20217:00 amRNSUnaudited Interim Results
26th Nov 20217:00 amRNSNotice of Half-year Results
15th Nov 20217:00 amRNSDirectorate Change
9th Nov 20217:00 amRNSInduction Attend Anywhere wins DWP contract
4th Nov 202110:52 amRNSResult of AGM
4th Nov 20217:00 amRNSAGM Statement
25th Oct 20217:00 amRNSReport on Video Consultations in Secondary Care
28th Sep 20217:00 amRNSPublication of Annual Report & Notice of AGM
23rd Sep 20217:00 amRNSFinal results for the year ended 31 March 2021
7th Sep 20217:00 amRNSDirectorate Changes
2nd Sep 20219:16 amRNSHolding(s) in Company
31st Aug 202111:04 amRNSHolding(s) in Company
22nd Jul 20217:00 amRNSBlock Listing Application
20th Jul 20217:00 amRNSMajor contract renewed with increased scope
16th Jun 20213:45 pmRNSHolding(s) in Company
11th Jun 20218:00 amRNSHolding(s) in Company
10th Jun 20214:18 pmRNSHolding(s) in Company
9th Jun 20218:00 amRNSCompletion of Acquisition of Attend Anywhere
8th Jun 20215:18 pmRNSHolding(s) in Company
7th Jun 202110:20 amRNSResult of General Meeting
21st May 20217:00 amRNSProposed Acquisition of Attend Anywhere Pty Ltd
18th May 20212:06 pmRNSSecond Price Monitoring Extn
18th May 20212:00 pmRNSPrice Monitoring Extension
18th May 202111:06 amRNSSecond Price Monitoring Extn
18th May 202111:01 amRNSPrice Monitoring Extension
18th May 20219:05 amRNSSecond Price Monitoring Extn
18th May 20219:00 amRNSPrice Monitoring Extension
26th Apr 20217:00 amRNSMultiple new hospital contracts for InductionZesty
25th Mar 20217:00 amRNSMulti-year hospital contract for Induction Switch
22nd Mar 20217:00 amRNSZesty surpasses 200k registered patients in the UK

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.